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ABSTRACT
Background: End-of-life (EOL) care is an important part of geriatric medicine in view of rap-
idly ageing populations in the world. 
Aim: We aimed to evaluate the quality of care for older patients with non-cancer terminal ill-
nesses, who died in 2010, under the EOL care program of an academic medical unit in Hong 
Kong. This unit consisted of an acute hospital, Prince of Wales Hospital (PWH) and a conva-
lescence hospital (Shatin Hospital, SH).
Methods: This was a retrospective hospital-based audit of clinical effectiveness of the EOL 
service. We reviewed the quality of patient care during the final seven days of life. The quality 
of care was evaluated based on the compliance rates of five selected goals and the adoption of 
futile life-sustaining procedures and treatments.
Results: Case records of 129 patients in the EOL care program were analyzed. Two goals, in-
cluding minimization of regular monitoring of vital signs and no blood taking, achieved over 
70% compliance at SH and 0% at PWH. The compliance rates of discontinuation of non-essen-
tial medications were 46.4% in SH and 47.1% in PWH; and the compliance rates of switching 
essential medications to non-oral routes were 63.4% in SH and 70.6% in PWH (not statistically 
significant). The compliance rates of using as-required intravenous or subcutaneous medica-
tions were extremely low (<2%) at both hospitals. All futile life-sustaining procedures and 
treatments were initiated at the PWH.
Conclusions: We demonstrated significant differences in the quality of EOL care between the 
acute hospital and convalescence hospital. Greater emphasis on specialist training and educa-
tion with allocation of resources may improve the EOL care in both settings.
KEYWORDS: End of life; Elderly; Chronic diseases; Advanced care plan; Palliative care.
ABBREVIATIONS: EOL: End-of-life; PWH: Prince of Wales Hospital; SH: Shatin Hospital; 
ACP: Advanced Care Plan; CHF: Congestive Heart Failure; COPD: Chronic Obstructive Pul-
monary Disease; ESRF: End-stage renal failure; DNR: Do Not Resuscitation; AED: Accident 
and Emergency Department; LCP: Liverpool Care Pathway; WHO: World Health Organiza-
tion; CPR: Cardiopulmonary resuscitation; AMT: Abbreviated Mental Test; OGD: Oesophago-
gastro-duodenoscopy; LCP: Liverpool Care Pathway; ACP: Advanced Care Planning.
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INTRODUCTION
 End of life (EOL) care is increasingly recognized as 
an essential component of healthcare system, but the access to 
EOL care service is far from satisfying the demand, particularly 
with an aging population in the world.1 It was also shown that 
older in-patients were more likely to suffer from inappropriate 
pain control and excessive interventions at the terminal stage 
of their lives.2 Therefore, it is important to deliver high quality 
EOL care for frail older patients by setting up an Advanced Care 
Plan (ACP), offering adequate pain and symptom control with-
out intention to hasten or postpone death, relieving caregivers’ 
burden and strengthening rapport with the relatives.3-6 In Hong 
Kong, people usually died in the hospital instead of at home or 
in the residential home in view of social culture and legislations. 
Most of the EOL care was therefore conveyed through the hospi-
tal setting. However, previous studies of EOL care have reported 
dissatisfaction from patients and their family members about 
symptom control and failure to address their physical and psy-
chosocial needs in the hospital setting.7-10 The aim of the study 
reported in this paper is to evaluate and compare the quality of 
EOL care for older patients with non-cancer diagnoses, in the 
acute and convalescence hospitals, by reviewing their clinical 
records during the last seven days of life.
EOL Care in Shatin Hospital, Hong Kong
 With a capacity of 300 medical beds, shatin hospital 
(SH) offers a sub-acute, convalescence and step-down care for 
patients transferred from the prince of wales hospital (PWH), 
which provides acute general medical services in New Territo-
ries East region with 0.7 million populations of which 12% are 
people aged over 65. In order to improve the quality of EOL 
care for non-cancer older patients with chronic illness, SH medi-
cal unit launched an EOL care program in 2008 for those with 
non-cancer chronic illnesses including Congestive Heart Failure 
(CHF), Chronic Obstructive Pulmonary Disease (COPD), End-
stage renal failure (ESRF), stroke, dementia, other neurodegen-
erative diseases, and frailty who approach their end stage of life. 
The focus of this program was to palliate symptoms, enhance 
patient and family satisfaction with palliative care services, and 
allow the patient to rest in his home environment for as long as 
possible during the final phase of life. There were three com-
mencing criteria:
1. Patient and relative not opting for active treatment; and
2. Existing Do Not Resuscitation (DNR) order; and
3. Satisfying the prognostic indicators of advanced disease of 
chronic illnesses.
 After identifying a potential case for the EOL care pro-
gram, the medical team in SH explain the program details to the 
patient and the family, and invite the patient to join the program 
by establishing an ACP and the DNR order. If the patient de-
veloped clinical deterioration, geriatricians might arrange direct 
clinical admission to SH for him to receive EOL care in their 
terminal stage of life. The patient would still be managed by the 
general medical team as there was no special palliative team in 
SH for caring the EOL cases. However, if the patient was criti-
cally ill, given that SH did not have Accident and Emergency 
Department (AED), the patient was inevitably sent to AED in 
other hospitals, most likely to PWH, for immediate treatment, 
because ambulance paramedics have to transport emergency pa-
tients to the nearest AED according to the government guideline. 
The patient might subsequently be resuscitated in AED and ad-
mitted to acute medical units in PWH for further care.
 Another similar project was undertaken in the oncol-
ogy unit of another regional hospital in Hong Kong from July 
to September 2009 on the use of integrated care pathway for 
EOL patients with cancer. The compliance rates of the following 
six selected items ranged from 80-100%, including: 1) discon-
tinuation of non-essential medications; 2) switching of essential 
medications to non-oral routes; 3) prescription of as-required in-
travenous or subcutaneous palliative medications; 4) minimiza-
tion of regular monitoring of vital signs; 5) practice of flexible 
visiting hours; and 6) order of ‘no further investigation’.9 
 In Hong Kong, there was a lack of data on the compli-
ance of EOL care pathway in acute vs. convalescence medical 
units. A typical example would be the use of unnecessary life-
sustaining procedures or treatments for older patients with termi-
nal non-cancer diseases despite their wishes for comfort care. 10-12 
METHODS
Method
 This was a retrospective hospital-based audit of clinical 
effectiveness of the EOL service in SH and PWH. We collected 
routine clinical data from the case notes and clinical manage-
ment system to review and compare the quality of EOL care 
provided during the final seven days of life for patients in SH 
and PWH. Since this was a retrospective audit with no novel 
intervention or collection of identifiable data, our study has the 
necessary ethical approval 
Patient Recruitment
 We retrospectively reviewed the clinical records of 
all the patients of EOL care program who died in 2010. Their 
socio-demographic characteristics, residential status, diagnoses, 
comorbidities, clinical characteristics (functional status, cogni-
tion, long-term use of naso-gastric feeding, urinary catheter and 
oxygen therapy), which reflected their background functional 
status, were recorded and summarized.
Evaluation Criteria of the Quality of EOL Care
 The quality of EOL care was assessed, based on: 1) the 
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compliance rates of five selected goals (see below), and 2) use of 
futile life-sustaining procedures and treatment in the last seven 
days of life. The five selected goals included: 1) discontinua-
tion of non-essential medications, 2) minimization of regular 
monitoring of vital signs, 3) no blood-taking, 4) use of as-re-
quired intravenous or subcutaneous palliative medications, and 
5) switching of essential medications to non-oral routes. These 
goals were adapted from the Liverpool Care Pathway (LCP) and 
the EOL care pathway used in the palliative care unit in Hong 
Kong, China. The compliance rate of each goal was calculated 
as the percentage of patients with goals achieved, with the gold 
standard being 100% compliance.
 Regarding the first goal, the World Health Organization 
(WHO) recommended a list of essential medications for use in 
palliative care in 2013, including morphine, ibuprofen, amitrip-
tyline, fluoxetine, diazepam, loperamide, lorazepam, haloperi-
dol, metoclopramide, dexamethasone, hyoscine hydrobromide, 
docusate sodium, senna and lactulose.13 In this study, medica-
tions in the same group of those listed above were classified as 
essential medications for symptom control in the dying phase. 
On the contrary, continuation of anti-hypertensive drugs, anti-
platelet drugs, glucose-lowering drugs, and mineral and electro-
lyte supplements in the last day of life was likely categorized as 
non-essential, but it should be reviewed case by case.
 For the fifth goal, prescription of essential medications 
was reviewed on the last day instead of the final seven days be-
cause patients might be able to eat initially and oral adminis-
tration of essential medications could be clinically appropriate 
then. Administration of medications via nasogastric or gastros-
tomy tube was considered appropriate in tube-fed patients.
Use of Futile Life-Sustaining Procedures and Treatments
 Use of futile life-sustaining procedures and treatments 
during the last seven days of life included 1) Cardiopulmonary 
resuscitation (CPR); 2) non-invasive and mechanical ventila-
tion; 3) use of inotropic agents and fluid resuscitation for hy-
potension or shock, and 4) the use of invasive diagnostic pro-
cedures. In Hong Kong, intravenous or subcutaneous hydration 
is commonly continued until death due to cultural reasons and 
family wishes, so this has not been counted as life-sustaining 
treatment in this audit.
Statistical Analysis
 Categorical variables were presented as counts and per-
centages, and continuous variables as mean values with standard 
deviations. The compliance rates of five selected goals in SH and 
PWH were compared and tested if there was a statistically sig-
nificant difference between two hospitals by using two samples 
z-test.
RESULTS
Clinical characteristics of EOL patients
 Table 1 summarizes the clinical characteristics of 146 
patients included in this audit. Over half (54.8%) of them were 
residing in nursing homes, and the mean duration of institution-
alization was 4.2 years. Stroke, which caused significant disabil-
ity and need for naso-gastric tube feeding, was the most common 
indication for EOL care (26%), followed by dementia (17.1%), 
chronic renal failure (15.8%), COPD (11.6%), congestive heart 
Demographics n (%) unless otherwise stated
Mean (SD) Age, years 83.4(±9.4)
Gender, male 66(45.2%)
Nursing home residents 80(54.8%)
Community-dwelling 66(45.2%)
Lived with children 30(45.5%)
Lived with spouses 29(43.9%)
Lived with other relatives 3(2.1%)
Lived alone 4(6.1%)
Availability of domestic helper 20(30.3%)
Main Diagnosis for EOL Care
Stroke 38(26.0%)
Advanced dementia 25(17.1%)
Chronic renal failure 23(15.8%)
Chronic obstructive pulmonary disease 17(11.6%)
Congestive heart failure 15(10.3%)
Frailty 14(9.6%)
Chronic liver disease 10(6.8%)
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failure (10.3%), frailty (9.6%) and chronic liver diseases (6.8%). 
Over 70% of the patients had very limited mobility (either chair-
bound or bedridden). 85 of the 146 patients (58.2%) were ver-
bally non-communicative. 139 of the 146 patients were assessed 
using the Abbreviated Mental Test (AMT) score, with the mean 
score of 2.2 (maximum score 10), of which 113 patients (81.3%) 
had a score equal to or lower than 5. The mean body mass index 
was 18.2 kg/m2 and mean serum albumin level was 27.8 g/l.
 The median length of stay of the last episode of hos-
pitalization was 17 days (range 1-193 days) at SH, and 3 days 
(range 1-20 days) at PWH. 131 of the 146 patients (89.7%) died 
within 6 months of being enrolled into the EOL care program. 
Nearly half of the patients (71/146, 48.6%) died during the same 
admission for which they were enrolled into the EOL care pro-
gram. 114 patients died at SH, 19 at PWH, 5 within the AED of 
PWH, and 8 at other hospitals.
Quality of EOL Care
 To study the compliance rates of the five selected goals, 
case notes regarding the clinical conditions of patients in the last 
seven days of life were reviewed. However, 5 out of 146 pa-
tients were certified dead within the AED of PWH, 8 died in 
other hospitals, and case notes of 4 patients were missing, so 
only case notes of 129 patients could be retrieved and data ana-
lyzed. Table 2 summarizes the compliance rates of five selected 
goals. Two goals, including minimization of regular monitoring 
of vital signs and no blood taking, achieved over 70% compli-
ance at SH, but 0% at PWH. The compliance rates of discontinu-
ation of non-essential medications in SH and PWH was 46.4% 
and 47.1% respectively without statistically significant differ-
ence (p=0.961). Over 90% of the patients continued with their 
anti-platelet or anticoagulant agents, over 80% with their anti-
hypertensive drugs, and over 30% received antibiotics during 
the last day of life. For the switching of essential medications to 
non-oral routes, the compliance rate in SH (63.4%) was lower 
than that in PWH (70.6%), but there was no statistically signifi-
cant difference (p=0.564). The compliance rate of prescribing 
as-required intravenous or subcutaneous palliative medications 
was extremely low (<2%) in both PWH and SH.
Use of Futile Life-Sustaining Procedures and Treatments
 Table 3 summarizes the number of futile life-sustaining 
procedures and treatments. All of these futile procedures and 
treatments were given in PWH, and none in SH.
 
DISCUSSION
 In this study, we assessed and compared the quality of 
Others 4(2.7%)
Comorbidities 
Mean number of comorbidities 5.4
Hypertension 93(63.7%)
Pressure ulcer 83(56.8%)
Cognitive impairment 76(52.1%)
Stroke 71(48.6%)
Anemia 62(42.5%)
Diabetes mellitus 53(37.0%)
Congestive heart failure 43(29.5%)
End-stage renal failure 41(28.1%)
Atrial fibrillation 32(21.9%)
Chronic obstructive pulmonary disease 30(20.5%)
Hip fracture 21(14.4%)
Clinical Characteristics
Mean (SD) Abbreviated Mental Test score (max 10) 2.2(±3.3)
Mean (SD) Norton Risk for pressure sore (max 30) 10.8(±3.7)
Mean (range) Number of oral medications 3(0–16)
Mobility status: bed-ridden 63(43.2%)
Mobility status: chair-bound 42(28.8%)
Mobility status: walk with or without aids 41(28.1%)
Long-term naso-gastric feeding 63(43.2%)
Long-term urinary catheterization 21(14.4%)
Long-term oxygen therapy 23(15.8%)
Table 1: Baseline characteristics of patients in this audit (N=146). 
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EOL care for older patients with non-cancer diagnoses under the 
EOL care program in the convalescence hospital vs. acute hospi-
tal by the compliance rates of five criteria, and the use of futile 
procedures and treatments. The results highlighted service gaps 
and areas for improvement in the EOL care program, particu-
larly within the acute hospital. The compliance rate of discon-
tinuation of non-essential medications was lower than 50% at 
both hospitals. These figures suggested that medications were 
less likely to be titrated according to the individual clinical con-
ditions towards the end of life. Compared with 100% compli-
ance rate reported in a similar study in a local oncology unit,14 
the lower compliance rate in our study might have resulted from 
insufficient guideline and staff awareness during initial assess-
ment. Minimizing the drug load by signing off relatively non-
essential medications should be emphasized for the sake of com-
fort care in any? medical unit.
 It was also shown that essential medications for symp-
tom control were less likely to be used at the acute hospital, 
for example, in the use of morphine. It was potentially associ-
ated with differences in the working culture between convales-
cence and acute hospitals. The concept of EOL care permeated 
throughout the convalescence unit of the convalescence hospi-
tal, so its clinical staff was better prepared to take care of the 
dying patients, especially in the aspect of symptom control. 
 Overall, the rate of using essential medications via non-
oral routes in the last days of life was fair (63.4%). However, 
the rate of prescribing as-required palliative medications via 
intravenous or subcutaneous route was low in both hospitals, 
below 2%. It signified a potential increased risk of inadequate 
symptom control in the final phase of life. The frequency of vital 
sign monitoring was noted to be much higher at the acute hospi-
tal compared to convalescence hospital. It should be noted that 
frequent monitoring of vital signs may cause unnecessary dis-
comfort, emotional arousal and anxiety among patients and their 
family members. Furthermore, any abnormal findings would 
lead to further excessive investigations, such as blood tests, X-
rays and electrocardiograms. Clinical staff should shift their at-
tention from routine monitoring of vital signs to focus on symp-
tom control, such as dyspnoea, pain, fever and restlessness. A 
higher priority should be placed on routine nursing care, includ-
ing mouth care, skin hygiene, turning and assisted oral intake. 
 Two of our study patients underwent invasive investi-
gations and procedures for the workup of malignancy (Oesoph-
ago-gastro-duodenoscopy (OGD) and abdominal paracentesis)), 
despite the fact that they were unlikely to be a candidate for sur-
gery, radiotherapy and chemotherapy, and their life expectancy 
was shorter than six months. Not only would the investigations 
not alter the treatment, they might also induce extra physical and 
psychological stress on the patients and their family members. 
Nonetheless, the DNR order was not equivalent to ‘no-treat-
ment’ order, and it could be worthwhile ordering investigations 
but only if the focus was to improve the quality of life, such as 
blood transfusion for symptomatic anemia, or thoracentesis for 
symptomatic pleural effusion. 
 Despite being offered direct admission to the convales-
cence hospital when necessary, many patients were admitted to 
the acute hospital through the AED, because of acute medical 
deterioration. They often spent a few days at the acute hospital 
before being transferred to convalescence. As mentioned like-
wise in an article review,15 patients at the acute hospital were 
handled by many different physicians with variable clinical ex-
pertise in EOL or geriatric care. Interns were usually the first 
medical contact to deal with the symptoms reported by the nurs-
es. It was not uncommon that some futile treatments were initi-
ated by the interns or junior medical staff (e.g. as non-invasive 
ventilation, fluid resuscitation and ordering blood and imaging 
tests), although many of which were subsequently stopped by 
Overall
(N=129)
SH
(n=112)
PWH
(n=17)
P-value
Discontinuation of non-essential medications 60 (46.5%) 52 (46.4%) 8 (47.1%) 1.000
Minimization of regular monitoring of vital signs 81 (62.8%) 81 (72.3%) 0 (0.0%) <0.001
No blood taking 87 (67.4%) 87 (77.7%) 0 (0.0%) <0.001
Use of as-required IV or SC palliative medications 2 (1.6%) 2 (1.8%) 0 (0.0%) 1.000
Switching of essential medications to non-oral routes 83 (64.3%) 71 (63.4%) 12 (70.6%) 0.787
Table 2: Compliance rates of five selected goals.
Table 3: Examples of futile treatments in the last 7 days at PWH.
Example Number of cases
Cardio-pulmonary resuscitation 6
Use of inotropic drugs for treatment of shock 3
Intubation 2
Non-invasive or mechanical ventilation 2
Fluid resuscitation for hypotension 2
Use of diagnostic Oesophago-Gastro-Duodenoscopy 1
Use of diagnostic abdominal paracentesis 1
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the attending physicians. These often happened during non-of-
fice hours or the middle of the night. Another major problem 
was a generally poor quality of documentation for decisions or 
treatment plans, such as whether there should be escalation of 
treatment in case of deterioration.
 The convalescence hospital had a palliative team with 
two hospice wards. It enabled medical officers to acquire more 
up-to-dated knowledge in symptom relief for the dying patients 
and other healthcare staff to have more opportunities for receiv-
ing training in EOL care. Moreover, EOL and palliative care ap-
proach were often promoted at clinical seminars and case pre-
sentations. All of these initiatives made a significant impact on 
patient care in this study. In addition, the independent review on 
Liverpool Care Pathway (LCP) in the United Kingdom (UK) 
pointed out that a care pathway itself would not guarantee a 
quality palliative care. It only worked well if operated by well-
trained, well-resourced, and sensitive clinical teams. Adequate 
training, education and resources should be offered to the front-
line clinical staff on top of provision of guidelines with a view 
to increasing their motivation and self-efficacy in adopting the 
LCP, as well as enhancing the communication with the patients 
and their carers.16-18 Moreover, the attending physicians should 
document clearly the decision and treatment plan in advance, 
after discussing with patients and/or their family members, so 
the on-call colleagues were able to deliver a consistent care.
 In Hong Kong, the law (Ambulance Ordinance) dic-
tates that patients with cardiorespiratory arrest in the community 
must be resuscitated. CPR was therefore initiated in six patients, 
who were found to be in cardiorespiratory arrest, by the am-
bulance crew. To avoid this futile life-sustaining procedure, it 
was of paramount importance to enhance the communication 
between the hospitals and the ambulance service on the EOL 
care program through the use of Advanced Care Planning (ACP) 
forms. These documents would allow the patients or their prox-
ies to clearly indicate the wish of life-sustaining treatment, such 
as intubation and CPR, in case of terminal illnesses, persistent 
vegetative state or in a state of irreversible coma. Moreover, the 
Ambulance Ordinance should be reviewed and amended, so that 
the DNR order for dying patients with an ACP could be respect-
ed by the ambulance crew. Professional development program 
in ACP for healthcare staff would be in place to promote their 
uptake of ACP.18 In addition, a detailed and clear documentation 
in the corporate electronic patient record about the EOL care 
plan could facilitate a better communication among healthcare 
providers even if the patients were admitted to different hospi-
tals in Hong Kong.
LIMITATIONS
 This study has several limitations. Firstly, in view of 
the retrospective nature of this study, some clinical information 
could not be retrieved from the case records, so the reasons for 
non-compliance were not fully evaluated in this study. Secondly, 
the quality indicators adopted in this study were modified from 
the LCP, which was strongly recommended for reform by an 
independent panel in 2013.17 It was revealed that the LCP could 
not perfectly fit into each of the cases, and there was a risk of 
over-emphasis on the protocol instead of the outcome of EOL 
care. In fact, the quality indicators we adopted were found to be 
capable of reviewing how the EOL care services provided rather 
than its outcome. Measurement of outcomes by using the ques-
tionnaires filled out by clinical staff and the family carer should 
be included in further studies to enable a more comprehensive 
assessment on the quality of EOL care.19 Thirdly, it was diffi-
cult to justify whether palliative medications on patients were 
“essential” in a retrospective review, as fair justification could 
not be made simply based on WHO recommended drug list. It 
should be considered with individual patient clinical context. 
Lastly, this was a small sample size in a local hospital in Hong 
Kong, so the results may not easily be generalizable to other 
populations.
CONCLUSION
 We found significant differences in the quality of 
EOL care for older people with non-cancer diagnoses between 
an acute hospital and a convalescence hospital in Hong Kong. 
Greater emphasis on specialist training and education, as well 
as allocation of resources is needed to improve EOL care. Since 
the completion of this study, our services have been redesigned 
to improve the EOL care for older people with non-cancer diag-
noses at both hospitals.
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